DEA Places Weight Loss Drug Lorcaserin into Schedule IV
The Drug Enforcement Administration placed the drug lorcaserin into Schedule IV of the Controlled Substances Act. The weight loss drug had been approved by the Food and Drug Administration in June 2012. Effective June 7, lorcaserin will be subject to new registration, labeling, recordkeeping, and import and export requirements, among other things.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
(Federal Register 05/08/13)